Hiroya Ikeda
- Hematology top 5%
- Genetics top 10%
- Oncology
- Immunology
- Surgery
- Topics
- Acute Myeloid Leukemia Research (4 papers)Management of metastatic bone disease (3 papers)Multiple Myeloma Research and Treatments (2 papers)
- Cited by
- HematologyGeneticsImmunology
In The Last Decade
Hiroya Ikeda
21 papers receiving 583 citations
Peers
Comparison fields: 5 of 57
- Hematology 192
- Genetics 156
- Oncology 139
- Immunology 131
- Surgery 126
Countries citing papers authored by Hiroya Ikeda
This map shows the geographic impact of Hiroya Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroya Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroya Ikeda more than expected).
Fields of papers citing papers by Hiroya Ikeda
This network shows the impact of papers produced by Hiroya Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroya Ikeda. The network helps show where Hiroya Ikeda may publish in the future.
Co-authorship network of co-authors of Hiroya Ikeda
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroya Ikeda. A scholar is included among the top collaborators of Hiroya Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroya Ikeda. Hiroya Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 2 | |
| 3 | [123I iomazenil SPECT and identification of the epileptogenic tubers in patients with tuberous sclerosis]. | 1 |
| 4 | 20 | |
| 5 | 30 | |
| 6 | [Retroperitoneal ganglioneuroma: a case report]. | 3 |
| 7 | [A rare case of high cervical spinal cord dural arteriovenous fistula presenting with intracranial subarachnoid hemorrhage]. | 18 |
| 8 | 8 | |
| 9 | Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor. | 12 |
| 10 | 4 | |
| 11 | 28 | |
| 12 | 63 | |
| 13 | 239 | |
| 14 | 8 | |
| 15 | 57 | |
| 16 | 1 | |
| 17 | 41 | |
| 18 | [Intraluminal irradiation with iridium-192 wires for extrahepatic bile duct carcinoma--a preliminary report (author's transl)]. | 3 |
| 19 | [Experimental spinal cord compression by epidural neoplasms (author's transl)]. | 1 |
| 20 | [Delayed radiation necrosis of the brain simulating a brain tumor--report of two cases (author's transl)]. | 1 |
About Hiroya Ikeda
Hiroya Ikeda is a scholar working on Hematology, Pathology and Forensic Medicine and Neurology, having authored 21 papers that have together received 594 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Management of metastatic bone disease (3 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Hematology (192 citations), Genetics (156 citations) and Immunology (131 citations). Hiroya Ikeda has collaborated with scholars based in Japan and India. Frequent co-authors include Yukitaka Ushio, Tõru Hayakawa, H Mogami, Jun Ishikawa, H. Kitayama, Y Kanayama, Y Kanakura, A Kuriu, Seiichiro Tarui and Tomoko Tamaki. Their work appears in journals such as Blood, Journal of neurosurgery and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.